Acinetobacter baylyi as a pathogen for opportunistic infection

Area of Science:

• Clinical Microbiology
• Infectious Diseases
• Antimicrobial Resistance

Background:

• Acinetobacter baylyi is a species not previously documented to cause human infections.
• Nosocomial infections pose a significant threat, particularly to vulnerable patient populations.

Purpose of the Study:

• To report the first cases of human infection caused by Acinetobacter baylyi.
• To characterize the clinical isolates and their antimicrobial resistance profiles.
• To assess the potential of A. baylyi as a human pathogen.

Main Methods:

• Identification of Acinetobacter baylyi using 16S-23S rRNA intergenic spacer and 16S rRNA gene analysis.
• Analysis of ribopatterns to assess clonal relationships among isolates.
• Antimicrobial susceptibility testing, including assessment for beta-lactamase production.

Main Results:

• Six patients presented with bacteremia due to Acinetobacter baylyi, all with underlying conditions.
• Five infections were nosocomially acquired, and isolates showed similar ribopatterns, suggesting a clonal origin.
• Clinical isolates exhibited increased resistance to antimicrobials, particularly beta-lactams, with potential plasmid-mediated beta-lactamases identified in some.

Conclusions:

• Acinetobacter baylyi is identified as a potential human pathogen capable of causing nosocomial infections.
• Immunocompromised patients are at risk for A. baylyi bacteremia.
• The emergence of antimicrobial resistance in these clinical isolates is a significant concern.